RECURSION PHARMACEUT
RXRX
 Delayed - 07/01 04:00:01 pm |
|
| 8.43USD | +3.56% |
Upcoming events on RECURSION PHARMACEUTICALS, INC.
| 08/12/22 | Interim 2022 Earnings Release (Projected) |
| 11/09/22 | Q3 2022 Earnings Release (Projected) |
| 03/22/23 | FY 2022 Earnings Release (Projected) |
| 05/10/23 | Q1 2023 Earnings Release (Projected) |
Past events on RECURSION PHARMACEUTICALS, INC.
| 06/28/22 | Morgan Stanley Putting the Tech in Biotech Conference |
| 06/14/22 | 02:00pm | Annual General Meeting |
| 06/13/22 | Goldman Sachs Global Healthcare Conference |
| 06/08/22 | Jefferies Healthcare Conference |
Upcoming sector events for RECURSION PHARMACEUTICALS, INC.
| 07/27/22 | VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected) |
| 07/27/22 | GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected) |
| 08/04/22 | REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release (Projected) |
| 08/08/22 | 08:00am | BIONTECH SE : Interim 2022 Earnings Call |
Past sector events for RECURSION PHARMACEUTICALS, INC.
| 06/29/22 | 08:00am | BIONTECH SE : Capital Markets Day |
| 06/23/22 | GILEAD SCIENCES, INC. : International Liver Congress |
| 06/22/22 | GILEAD SCIENCES, INC. : EASL International Liver Congress - Poster No - 0832 |
| 06/22/22 | GILEAD SCIENCES, INC. : EASL International Liver Congress - Poster No - 0660 |
Annual results
| Fiscal Period : December | 2021 | 2022 | ||||||
| Sales M $ |
Released Forecast Spread | 10,2 12,4 -18% | 44,5 | |||||
| Operating income (EBITDA) M $ |
Released Forecast Spread | -174 -175 0,11% | -245 | |||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | -183 -174 -4,9% | -238 | |||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -186 -163 -14% | -225 | |||||
| Net income M $ |
Released Forecast Spread | -186 -177 -5,5% | -222 | |||||
| EPS $ |
Released Forecast Spread | -1,49 -1,20 -24% | -1,53 | |||||
| Announcement Date | 03/23/2022 | - | ||||||
| ||||||||
Previous year
Quarterly / Semiannualy publications
| Fiscal Period : December | 2022 Q1 | 2022 Q2 | |||||||||||||||
| Sales M $ |
Released Forecast Spread | 5,33 84,0 -94% | 5,40 | ||||||||||||||
| Operating profit (EBIT) M $ |
Released Forecast Spread | -56,0 -52,0 -7,7% | -65,6 | ||||||||||||||
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -57,0 | |||||||||||||||
| Net income M $ |
Released Forecast Spread | -56,0 87,3 -164% | -60,6 | ||||||||||||||
| EPS $ |
Released Forecast Spread | -0,33 0,51 -165% | -0,35 | ||||||||||||||
| Announcement Date | 05/10/2022 | - | |||||||||||||||
| |||||||||||||||||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
